Pacific Biosciences of California-Pacific Biosciences (PACB) Reports Q1 Earnings: What Key Metrics Have to Say

For the quarter ended March 2025, Pacific Biosciences of California (PACB) reported revenue of $37.15 million, down 4.3% over the same period last year. EPS came in at -$ 0.15, compared to - $0.26 in the year-ago quarter.The reported revenue represents a surprise of +6.15% over the Zacks Consensus Estimate of$ 35 million. With the consensus EPS estimate being -$0.19, the EPS surprise was +21.05%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they co ...